Alle RRMS-patiënten en degenen met SPMS waarbij de relaps het dominerende klinische kenmerk is en die voldoen aan de criteria van de ABN (Association of British Neurologists) komen in aanmerking voor behandeling krachtens deze regeling.
All patients with relapsing-remitting MS, and those with secondary progressive MS in which relapses are the dominant clinical feature, who meet the criteria developed by the ABN (Association of British Neurologists) are eligible for treatment under this scheme".